Evidence map›Paper›PMID 33925691›Full record

ReviewInternational journal of molecular sciences2021

Role of ABCA7 in Human Health and in Alzheimer's Disease.

Shiraz Dib, Jens Pahnke, Fabien Gosselet

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Long-read sequencing reveals genomic and epigenomic variation in the dark genome of human Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 4 countries.

Shiraz DibUR2465, LBHE-Blood-Brain Barrier Laboratory, University Artois, 62300 Lens, France.
Jens PahnkeDepartment of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.ORCID 0000-0001-7355-4213
Fabien GosseletUR2465, LBHE-Blood-Brain Barrier Laboratory, University Artois, 62300 Lens, France.ORCID 0000-0002-0481-5026
Université d'Artois · FROslo University Hospital · NO

Funding

Agence Nationale de la Recherche (ANR) ANR-20-JPW2-0002-04Artois University BQR-ABCA7Barnekreftforeningen 19008Deutsche Forschungsgemeinschaft DFG 263024513EEA grant/Norges grants TAČR TARIMAD TO100078European Union's Horizon 2020 research and innovation program #643417France Alzheimer et Maladies apparentées #22,2013HelseSØ 2019054, 2019055Latvian Council of Science lzp-2018/1-0275Ministerium für Wirtschaft und Wissenschaft Sachsen-Anhalt/ Germany ZS/2016/05/78617Nasjonalforeningen 16154
6 · The paper itself

Abstract

Several studies, including genome wide association studies (GWAS), have strongly suggested a central role for the ATP-binding cassette transporter subfamily A member 7 (ABCA7) in Alzheimer's disease (AD). This ABC transporter is now considered as an important genetic determinant for late onset Alzheimer disease (LOAD) by regulating several molecular processes such as cholesterol metabolism and amyloid processing and clearance. In this review we shed light on these new functions and their cross-talk, explaining its implication in brain functioning, and therefore in AD onset and development.

Indexed as

Alzheimer DiseaseAmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorATP-Binding Cassette TransportersBrainCholesterolGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPhagocytosisPolymorphism, Single NucleotideABCA7 protein, humanAmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorATP-Binding Cassette TransportersCholesterolABCA7Alzheimer’s diseaseAβ peptidescholesterolphagocytosis

Identifiers

PMID33925691
PMCPMC8124837
OpenAlexW3158867024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.